Literature DB >> 24511375

Mathematical models of immune-induced cancer dormancy and the emergence of immune evasion.

Kathleen P Wilkie1, Philip Hahnfeldt1.   

Abstract

Cancer dormancy, a state in which cancer cells persist in a host without significant growth, is a natural forestallment of progression to manifest disease and is thus of great clinical interest. Experimental work in mice suggests that in immune-induced dormancy, the longer a cancer remains dormant in a host, the more resistant the cancer cells become to cytotoxic T-cell-mediated killing. In this work, mathematical models are used to analyse the possible causative mechanisms of cancer escape from immune-induced dormancy. Using a data-driven approach, both decaying efficacy in immune predation and immune recruitment are analysed with results suggesting that decline in recruitment is a stronger determinant of escape than increased resistance to predation. Using a mechanistic approach, the existence of an immune-resistant cancer cell subpopulation is considered, and the effects on cancer dormancy and potential immunoediting mechanisms of cancer escape are analysed and discussed. The immunoediting mechanism assumes that the immune system selectively prunes the cancer of immune-sensitive cells, which is shown to cause an initially heterogeneous population to become a more homogeneous, and more resistant, population. The fact that this selection may result in the appearance of decreasing efficacy in T-cell cytotoxic effect with time in dormancy is also demonstrated. This work suggests that through actions that temporarily delay cancer growth through the targeted removal of immune-sensitive subpopulations, the immune response may actually progress the cancer to a more aggressive state.

Entities:  

Keywords:  cancer dormancy; immunoediting; mathematical model

Year:  2013        PMID: 24511375      PMCID: PMC3915830          DOI: 10.1098/rsfs.2013.0010

Source DB:  PubMed          Journal:  Interface Focus        ISSN: 2042-8898            Impact factor:   3.906


  45 in total

1.  Data-driven modelling of receptor tyrosine kinase signalling networks quantifies receptor-specific potencies of PI3K- and Ras-dependent ERK activation.

Authors:  Murat Cirit; Jason M Haugh
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

Review 2.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

3.  Marked cyclic leukocytosis-leukopenia in chronic myelogenous leukemia.

Authors:  A R Rodriguez; C L Lutcher
Journal:  Am J Med       Date:  1976-06       Impact factor: 4.965

4.  Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy.

Authors:  Heiko Enderling; Philip Hahnfeldt; Lynn Hlatky; Nava Almog
Journal:  Cancer Res       Date:  2012-03-13       Impact factor: 12.701

Review 5.  Mathematical models of cancer dormancy.

Authors:  Karen Page; Jonathan W Uhr
Journal:  Leuk Lymphoma       Date:  2005-03

6.  PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.

Authors:  Michael A Curran; Welby Montalvo; Hideo Yagita; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

7.  Adaptive immunity maintains occult cancer in an equilibrium state.

Authors:  Catherine M Koebel; William Vermi; Jeremy B Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Journal:  Nature       Date:  2007-11-18       Impact factor: 49.962

8.  Cyclic oscillation of blood neutrophils in a patient with multiple myeloma.

Authors:  G Chikkappa; A D Chanana; P Chandra; E P Cronkite; K H Thompson
Journal:  Blood       Date:  1980-01       Impact factor: 22.113

Review 9.  Immune-mediated dormancy: an equilibrium with cancer.

Authors:  Michele W L Teng; Jeremy B Swann; Catherine M Koebel; Robert D Schreiber; Mark J Smyth
Journal:  J Leukoc Biol       Date:  2008-05-30       Impact factor: 4.962

10.  Spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases.

Authors:  J G Krikorian; C S Portlock; P Cooney; S A Rosenberg
Journal:  Cancer       Date:  1980-11-01       Impact factor: 6.860

View more
  10 in total

1.  Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape.

Authors:  Li Wenbo; Jin Wang
Journal:  J R Soc Interface       Date:  2017-06       Impact factor: 4.118

Review 2.  Mathematical modeling of tumor-immune cell interactions.

Authors:  Grace E Mahlbacher; Kara C Reihmer; Hermann B Frieboes
Journal:  J Theor Biol       Date:  2019-03-02       Impact factor: 2.691

3.  An agent-based modeling framework linking inflammation and cancer using evolutionary principles: description of a generative hierarchy for the hallmarks of cancer and developing a bridge between mechanism and epidemiological data.

Authors:  Gary An; Swati Kulkarni
Journal:  Math Biosci       Date:  2014-08-01       Impact factor: 2.144

4.  Modeling putative therapeutic implications of exosome exchange between tumor and immune cells.

Authors:  Mingyang Lu; Bin Huang; Samir M Hanash; José N Onuchic; Eshel Ben-Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

5.  Cancer-induced immunosuppression can enable effectiveness of immunotherapy through bistability generation: A mathematical and computational examination.

Authors:  Victor Garcia; Sebastian Bonhoeffer; Feng Fu
Journal:  J Theor Biol       Date:  2020-02-06       Impact factor: 2.691

Review 6.  Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies.

Authors:  Erica Pranzini; Giovanni Raugei; Maria Letizia Taddei
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

Review 7.  Integrative lymph node-mimicking models created with biomaterials and computational tools to study the immune system.

Authors:  Yufeng Shou; Sarah C Johnson; Ying Jie Quek; Xianlei Li; Andy Tay
Journal:  Mater Today Bio       Date:  2022-04-21

8.  A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation.

Authors:  Sotiris Prokopiou; Eduardo G Moros; Jan Poleszczuk; Jimmy Caudell; Javier F Torres-Roca; Kujtim Latifi; Jae K Lee; Robert Myerson; Louis B Harrison; Heiko Enderling
Journal:  Radiat Oncol       Date:  2015-07-31       Impact factor: 3.481

Review 9.  Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.

Authors:  Antonella Sistigu; Martina Musella; Claudia Galassi; Ilio Vitale; Ruggero De Maria
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

Review 10.  How Should Cancer Models Be Constructed?

Authors:  Robert A Beckman; Irina Kareva; Frederick R Adler
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.